Friday, 5 February 2016

Corporate News Update

CAPITALSTARS

 DAILY CORPORATE NEWS


Lupin jumps as Q3 earnings give positive surprise; profit, revenue beats estimate
Shares of Lupin surged 10% to Rs1803 on NSE post Q3FY2016 results which came better than expectations.
Lupin has announced the following results for the quarter ended December 31, 2015:
Standalone (YoY)
Net Profit rose by 49.31% to Rs766.42 crore Vs Rs513.30 crore.
Total Income increased by 21.45% to Rs2922.25 crore Vs Rs2406.03 crore.

Bosch announces Q3 net profit at Rs221 crore
Bosch Q3: Net Profit at Rs221 Cr Vs Rs111 Cr (YoY)
Total Income at Rs2,698 Cr Vs Rs2,381.6 Cr (YoY)
EBITDA +52.4% at Rs347.3 Cr Vs Rs228 Cr (YoY)

Eicher Motors spurts on robust Q3 consolidated net profit
Shares of Eicher Motors surged 8% to Rs18450 on NSE post Q4FY15 results led by strong performance sustains despite Chennai floods
Eicher Motors has announced the following results for the quarter ended December 31, 2015 (YoY):
Standalone (YoY)
Net Profit rose by 97.46% to Rs245.01 crore Vs Rs124.08 crore.
Total Income increased by 56.58% to Rs1304.81 crore Vs Rs833.28 crore.

Cadila rallies on better than expected Q3 consolidated net profit
Shares of Cadila Healthcare rallied 5% to Rs327 on NSE post better than expected Q3FY2016 results.
Cadila Healthcare has announced the following Q3 results for the quarter ended December 31, 2015 (YoY):
Standalone (YoY)
Net Profit rose by 30% to Rs469.50 crore Vs Rs361.20 crore.
Total Income increased by 20.36% to Rs1775.50 crore Vs Rs1475.10 crore.

Torrent Pharma gains on strong Q3 performance
Shares of Torrent Pharma gained over 2% to Rs1371.90 on NSE led by strong Q3 performance; upgrade to BUY with PT of Rs1, 741
Result Synopsis: Sales for the quarter reported growth of 33.1% to Rs 1539 crores; operating profit grew by 155.4% to Rs 613 crores; operating profit margin improved by 1698bps to 31.4% and profit for the quarter grew by 189.2% to Rs483 crore.
Strong performance driven mainly by US: For Q3FY2016, Torrent Pharmaceuticals (Torrent Pharma) results were ahead of expectation largely due to higher-than-expected revenues from its launches like gAbilify, gDetrol LA, gNexium and gNamenda in USA (up 226% YoY).

Related Posts:

  • IT index at 52-week lows, TCS 4% Rolled IT firm Cognizant sluggish growth in revenue in the first quarter is expected to be released. Weak conjecture on the IT sector is seeing huge pressure.Anais's IT index has a 52-week low. TCS, Wipro and Infosys is seeing… Read More
  • Corporate News Update CAPITALSTARS  DAILY CORPORATE NEWS PNB drops on sharp rise in Q3FY16 NPAs, loss at PBT level Shares of PNB dropped 6% to Rs89 on NSE post Q3FY16 results led by sharp rise in NPAs, loss at PBT level Punjab Natio… Read More
  • Performance Of The Day CS PERFORMANCE MESSAGE: STOCK FUTURES: FUTURES INTRADAY: LUPIN FUTURE  BUY CALL 3  TG TATAMTRDVR  FUTURE SELL CALL 3 TG NIFTY FUTURES: NIFTY FUTURE SELL CALL 2 TG OPTION: TATAMOTORS 320 PUT BUY CALL 3 TG… Read More
  • INDIAN BENCHMARKS MARKET WRAP-UP UPDATES INDIAN BENCHMARKS: SENSEX PLUNGES 266 POINTS NIFTY 50 DROPS BELOW 7300 Top IT and banking stocks pulled the domestic equity benchmarks down on Tuesday amid a global selloff in equities, as the market extended the los… Read More
  • MCX Bullion News Updates Gold prices-Gold prices fell in Asia Tuesday on profit taking as investors looked look ahead to views on U.S. interest rates this week. Investors await an appearance by Federal Reserve chair Janet Yellen before the House Fi… Read More

0 comments:

Post a Comment

Blog Archive

Powered by Blogger.